Drug
Lispro Mix 75 25
Lispro Mix 75 25: highest development phase Post-Market, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lispro mix 75/25 NCT00551538 | Post-Market | Type 2 Diabetes |
Latest
No recent events.
Follow Lispro Mix 75 25 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.